Investing Profile
Carlos Solórzano
Your Intro Paths to Carlos Solórzano
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Carlos is a member of
Deutsche Bank Network
52 CONNECTIONS
University of California, Irvine Network
11 CONNECTIONS
Find Carlos Solórzano on
cbCurrent Investing Position
Section 32 Principal
Previous Investment Position
Pivotal bioVenture Partners Sr. Associate
Investment Range
$10K - $50K
Sweet Spot
$25K
Current Fund Size
$740M
Carlos Solórzano is on these Sector & Stage Rankings
BioTech (Series B)BioTech (Seed)Health & Hospital Services (Series B)Health IT (Series A)BioTech (Series A)Health & Hospital Services (Series A)San Francisco Bay AreaDigital Health (Series B)Therapeutics (Series A)Therapeutics (Seed)Therapeutics (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)
Carlos Solórzano's Experience
Sr. Principal Section 322022 - Present
Sr. Associate Pivotal Life Sciences2019 - 2022
Sr. Associate Pivotal bioVenture Partners2019 - 2022
Assoc Director, Corporate Strategy Ultragenyx Pharmaceutical Inc.2018 - 2019
Equity Research Associate - Biotechnology Deutsche Bank2016 - 2018
Equity Research Associate - Biotechnology Oppenheimer & Co. Inc.2015 - 2016
NIH Postdoctoral Fellow University of California, San Francisco2010 - 2015
President - Bay Area Chapter Oxbridge Biotech Roundtable2014 - 2014
Carlos Solórzano's Education
Keck Graduate Institute Intensive Summer Business Course
University of California, Irvine Ph.D. Pharmacology and Toxicology
California State Polytechnic University-Pomona B.Sc. Chemical Engineering
Investors who invest with Carlos Solórzano
Founders who looked at Carlos Solórzano's profile also looked at these Scouts & Angels